[5]
Before selling a "new drug", as that term is defined in the
FDA
, a manufacturer must obtain a Notice of Compliance ("NOC") from the Minister. The issuance of an NOC constitutes marketing approval. This matter arises because Nu-Pharm is seeking approval for a Nu-Pharm NDS and accordingly seeks an NOC from the Minister.